Cibus (CBUS) Work In Process (2019 - 2020)
Cibus (CBUS) posted Work In Process of $341000.0 for Q3 2020, down 38.34% sequentially from $553000.0 in Q2 2020, and down 0.58% YoY from $343000.0 in Q4 2019.
Cibus (CBUS) Work In Process (2019 - 2020) Analysis & Trends
Cibus has reported Work In Process for 2 years, with the latest figure at $341000.0 in Q3 2020.
- Quarterly Work In Process fell 0.58% year-over-year to $341000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $341000.0 (down 0.58% YoY) and the FY2019 annual result came in at $272000.0, changed N/A from the prior year.
- Work In Process eased to $341000.0 in Q3 2020 per CBUS's latest filing, from $553000.0 in the prior quarter.
- Over five years, Work In Process peaked at $553000.0 in Q2 2020 and troughed at $18000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 341,000.00 |
| Jun 30, 2020 | 553,000.00 |
| Mar 31, 2020 | 445,000.00 |
| Dec 31, 2019 | 272,000.00 |
| Sep 30, 2019 | 343,000.00 |
| Jun 30, 2019 | 18,000.00 |